DaVita Inc. (0I7E.L)
| Previous close | 142.57 |
| Open | 138.26 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 131.82 - 143.00 |
| 52-week range | 71.57 - 143.00 |
| Volume | |
| Avg. volume | 1,554 |
| Market cap | 223.236M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 0.16 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
DaVita Inc. 1st Quarter 2024 Results
DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended March 31, 2024.
- PR Newswire
DaVita's Global Operations Powered by 100% Renewable Energy
By 2025, DaVita (NYSE: DVA), a leading provider of kidney care services, expects to match 100% of its electricity use across its global operations with renewable energy purchases. DaVita has contracted with ACCIONA Energía on a virtual power purchase agreement (PPA) facilitating the development of clean energy projects in Spain. This announcement follows DaVita reaching 100% renewable in its North American operations in December 2021.
- PR Newswire
DaVita Inc. Schedules 1st Quarter 2024 Investor Conference Call
DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Thursday, May 2, 2024, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day.
